c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
InflaRx (IFRX) Launches Phase 2 Trials for Izicopan Targeting ANCA-Associated Vasculitis
GuruFocus | Nov 3, 2026 9:51 AM EST
Related Stocks: IFRX ,
Read original article